Public consultation on applications to be considered by the MSAC (July 2023)

Overview

Consultation is now open for applications that are anticipated to be considered by the Medical Services Advisory Committee (MSAC) on 27-28 July 2023  

MSAC values consultation input from individuals and organisations with an interest in an application that it is considering, including experience of the medical conditions, services or technologies being addressed by the application.   

It is anticipated that the below-mentioned applications will proceed to MSAC in July 2023. Consultation input must be received by no later than          Friday, 9 June 2023 for it to be considered by MSAC. A consultation survey form is available on the relevant application webpage.

Further information on MSAC’s consultation process is also available on the MSAC website.

Applications scheduled to be considered:

Resubmissions:

1686.1 –177Lutetium PSMA i&t for metastatic castrate resistant prostate cancer

1689.1 - Quantification of NT-proBNP in patients with systemic sclerosis, and in patients with diagnosed pulmonary arterial hypertension

New submissions:

1657 – Rhenium-188 brachytherapy for non-melanoma skin cancer

1710 – Newborn bloodspot screening for X-linked adrenoleukodystrophy

1732 – Imlifidase as a desensitisation treatment to enable kidney transplant in highly sensitised adult transplant candidates

1737 – Newborn bloodspot screening for Sickle Cell Disease and Beta Thalassaemia

1747 – Permanent Medicare Benefits Schedule (MBS) items for COVID-19 nucleic acid testing

1748 – Review of Tisagenlecleucel for treatment of confirmed relapsed/refractory CD19-positive acute lymphoblastic leukaemia in children and young adults up to 25 years old

What happens next

Once the consultation closes, submissions will be compiled and considered by MSAC.

Once it has finalised its appraisal of an application for public funding, MSAC publishes a Public Summary Document (PSD). The PSD captures MSAC deliberations and key advice to the Minister, which is generally to either support funding; not support funding; or defer consideration. 

PSDs are generally published approximately three (3) months after the MSAC meeting at which the application was considered. The PSD can be located on the relevant application webpage on the MSAC website.